Abzena Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 430

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 17

  • Investments
  • 4

Abzena General Information

Description

Manufacturer of complex biologics and bioconjugate services built for de-risking and accelerating drug development from discovery through commercial launch. The company's integrated drug development ecosystem, including cell line platforms, immunogenicity testing, inker-payload conjugation, rapid analytics, and biologics manufacturing facilities, is providing biopharma and biotech clients with end-to-end, scientifically robust, and regulatory-compliant solutions that streamline scale-up and improve time-to-clinic outcomes.

Contact Information

Website
www.abzena.com
Formerly Known As
PolyTherics
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Babraham Research Campus
  • Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Babraham Research Campus
  • Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abzena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abzena‘s full profile, request access.

Request a free trial

Abzena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of complex biologics and bioconjugate services built for de-risking and accelerating drug development from
Other Pharmaceuticals and Biotechnology
Cambridge, United Kingdom
430 As of 2025

Newcastle upon Tyne, United Kingdom
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abzena Competitors (36)

One of Abzena’s 36 competitors is Alcyomics, a Formerly VC-backed company based in Newcastle upon Tyne, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alcyomics Formerly VC-backed Newcastle upon Tyne, United Kingdom
Celonic Corporate Backed or Acquired Basel, Switzerland
Xoma Corporate Backed or Acquired Emeryville, CA
Precigen Formerly VC-backed Germantown, MD
AC Immune Formerly VC-backed Lausanne, Switzerland
You’re viewing 5 of 36 competitors. Get the full list »

Abzena Patents

Abzena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201708105-D0 Antibodies, uses thereof and conjugates thereof Inactive 19-May-2017
US-10654873-B2 Cytotoxic agents and conjugates thereof Active 15-Sep-2016
ES-2882016-T3 New cytotoxic agents and their conjugates Active 15-Sep-2016
EP-3512856-A1 Novel cytotoxic agents and conjugates thereof Active 15-Sep-2016
EP-3512856-B1 Novel cytotoxic agents and conjugates thereof Active 15-Sep-2016 C07D498/18
To view Abzena’s complete patent history, request access »

Abzena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abzena Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Abzena‘s full profile, request access.

Request a free trial

Abzena Acquisitions (4)

Abzena’s most recent deal was a Merger/Acquisition with The Chemistry Research Solution for . The deal was made on 24-Nov-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
The Chemistry Research Solution 24-Nov-2015 Merger/Acquisition Biotechnology
Pacific GMP 14-Sep-2015 Merger/Acquisition Laboratory Services (Healthcare)
Antitope 26-Jul-2013 Merger/Acquisition Other Commercial Services
Warwick Effect Polymers 20-Jan-2012 Merger/Acquisition Specialty Chemicals
To view Abzena’s complete acquisitions history, request access »

Abzena Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Antitope Cambridge, United Kingdom 2004

Abzena FAQs

  • When was Abzena founded?

    Abzena was founded in 2001.

  • Where is Abzena headquartered?

    Abzena is headquartered in Cambridge, United Kingdom.

  • What is the size of Abzena?

    Abzena has 430 total employees.

  • What industry is Abzena in?

    Abzena’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Abzena a private or public company?

    Abzena is a Private company.

  • What is Abzena’s current revenue?

    The current revenue for Abzena is .

  • How much funding has Abzena raised over time?

    Abzena has raised $122M.

  • Who are Abzena’s investors?

    Beringea, Bloomsbury Bioseed Fund, Catapult Ventures, Comer Woodford Ventures, and IP Group are 5 of 16 investors who have invested in Abzena.

  • Who are Abzena’s competitors?

    Alcyomics, Celonic, Xoma, Precigen, and AC Immune are some of the 36 competitors of Abzena.

  • When was Abzena acquired?

    Abzena was acquired on 01-Feb-2026.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process